Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: TSX recovering as key stocks eye a comeback

The TSX has been on a rebound, clawing back to levels seen before the great global selloff that marked the beginning of the month. As the market stabilizes, investors are keenly watching certain TSX-listed stocks that have recently faced setbacks but are striving to reg...
Jonathon Brown | August 15, 2024 |

DynaCERT: Is this the hour of hydrogen?

Daimler Truck must reduce forecasts It is a challenging time for transportation companies. By 2030, fleet operators in the EU will have to meet specific requirements to reduce CO2 emissions. The EU has introduced stricter CO2 standards for heavy-duty vehicles, requi...
Armin Schulz | August 12, 2024 |

Revolutionizing immunotherapies with groundbreaking DPX platform

The following is a transcription of the above video, and The Market Online has edited it for clarity . BioVaxys Technology Corp (CSE:BIOV) is a Canadian-based clinical stage biopharmaceutical company focused on improving patient lives with novel immunotherapies. CE...
Lyndsay Malchuk | July 30, 2024 |

Buzz on the Bullboards: Whose stocks sizzle during summer holidays?

As we get through the summer holiday season, the typically calmer market environment presents a prime opportunity for investors to evaluate their portfolios and consider new investments. The TSX continues to offer a variety of promising stocks, particularly in energ...
Jonathon Brown | July 4, 2024 |

Buzz on the Bullboards: Looking for volatility-proof stocks?

This week, investors witnessed significant developments in Canadian and U.S. markets, with attention drawn to the pivotal decisions made by central banks and notable movements in key sectors. Let’s get into the highlights of the past week’s...
Jonathon Brown | April 11, 2024 |

Buzz on the Bullboards: Good stocks with bad publicity

It was hedge fund legend Ray Dalio who said: “He who lives by the crystal ball will eat shattered glass.” Many stock markets may have seen a higher start to the year so far, but there is far from a universal sentiment across the sectors, with s...
Jonathon Brown | January 25, 2024 |

Pharmaceutical company treats bladder cancer with new tech

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Theralase Technologies Inc. (TSXV:TLT) , a clinical-stage pharmaceutical company, is currently developing an innovative, research-backed technology for the ...
Ryan Dhillon | January 8, 2024 |

Buzz on the Bullboards: Markets underperforming, or is the best yet to come?

So, the “September rally” didn’t really pan out as many indices hit lows not seen in months, but at least interest rates were kept firm for now, so that is some good news, right? Investors have been worried about the possibility o...
Jonathon Brown | September 28, 2023 |

ExoTherapy offers hope for treating acute spinal cord injuries

Suffering from traumatic injuries can leave a person with long-term damages and/or side effects that are hard to navigate long after the initial incident has passed. Our next company is a publicly traded bio-pharmaceutical company, working on the development of its ...
Brieanna McCutcheon | September 19, 2023 |

Buzz on the Bullboards: Creating Cash out of an Economy Crunch

(Image via Bombardier Inc.) If you’re looking to see the stocks that investors have been keeping an eye on over the past week, you’ve come to the right place. The Stockhouse community regularly acts as a microcosm of investor sen...
Stockhouse Editorial | May 25, 2022 |
1 2 3 4 5 6 7 8 9 10 ...